Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 4/2012

01-08-2012 | Case Report

Fungemia due to Rhodotorula mucilaginosa in an immunocompetent, critically ill patient

Authors: Jesús Monterrubio Villar, Carmen González Velasco, Juan Diego Jiménez Delgado

Published in: Journal of Infection and Chemotherapy | Issue 4/2012

Login to get access

Abstract

Infections due to the yeast Rhodotorula are rare in humans. R. mucilaginosa is responsible for the majority of human cases, and immunocompromised individuals with central venous catheters are at greatest risk. There are few reports of bloodstream infections due to R. mucilaginosa in immunocompetent patients. We present a case report of fungemia due to R. mucilaginosa in an immunocompetent, critically ill patient, with good evolution with catheter removal and fluconazole therapy. We briefly review the spectrum of infections due to R. mucilaginosa and the management of bloodstream infections due to this yeast.
Literature
1.
Fell JW, Boekhout T, Fonseca A, Scorzetti G, Statzell-Tallman A. Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis. Int J Syst Evol Microbiol. 2000;50(3):1351–71.PubMedCrossRef
2.
Chung JW, Kim BN, Kim YS. Central venous catheter-related Rhodotorula rubra funguemia. J Infect Chemother. 2002;8(1):109–10.PubMed
3.
Kiraz N, Gülbas Z, Akgün Y. Case report. Rhodotorula rubra funguemia due to use of indwelling venous catheters. Mycoses. 2000;43(5):209–10.PubMedCrossRef
4.
Petrocheilou-Paschou V, Prifti H, Kostis E, Papadimitriou C, Dimopoulos MA, Stamatelopoulos S. Rhodotorula septicemia: case report and minireview. Clin Microbiol Infect. 2001;7(2):100–2.PubMedCrossRef
5.
Silva V, Zepeda G, Rybak ME, Febre N. Yeast carriage on the hands of medicine students. Rev Iberoam Micol. 2003;20(2):41–5.PubMed
6.
Louria DB, Blevins A, Armstrong D, Burdick R, Lieberman P. Fungemia caused by “nonpathogenic” yeasts. Arch Intern Med. 1967;119(3):247–52.PubMedCrossRef
7.
Hagan ME, Klotz SA, Bartholomew W, Potter L, Nelson M. A pseudoepidemic of Rhodotorula rubra: a marker for microbial contamination of the broncoscope. Infect Control Hosp Epidemiol. 1995;16(12):727–8.PubMedCrossRef
8.
Kiehn TE, Gorey E, Brown AE, Edwards FF, Armstrong D. Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clin Infect Dis. 1992;14(4):841–6.PubMedCrossRef
9.
Maeder M, Vogt PR, Schaer G, von Graevenitz A, Günthard HF. Aortic homograft endocarditis caused by Rhodotorula mucilaginosa. Infection. 2003;31(3):181–3.PubMed
10.
Unal A, Koc AN, Sipahioglu MH, Kavuncuoglu F, Tokgoz B, Buldu HM, et al. CAPD-related peritonitis caused by Rhodotorula mucilaginosa. Perit Dial Int. 2009;29(5):581–2.PubMed
11.
Goyal R, Das S, Arora A, Aggarwal A. Rhodotorula mucilaginosa as a cause of persistent femoral nonunion. J Postgrad Med. 2008;54(1):25–7.PubMedCrossRef
12.
Lunardi LW, Aquino VR, Zimerman RA, Goldani LZ. Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital. Clin Infect Dis. 2006;43(6):e60–3.PubMedCrossRef
13.
Samonis G, Anatoliotaki M, Apostolakou H, Maraki S, Mavroudis D, Gergoulias V. Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature. Infection. 2001;29(3):173–6.PubMedCrossRef
14.
García-Martos P, Domínguez I, Marín P, García-Agudo R, Aoufi S, Mira J. Antifungal susceptibility of emerging yeast pathogens. Enferm Infecc Microbiol Clin. 2001;19(6):249–56.PubMed
15.
Zaas AK, Boyce M, Schell W, Lodge BA, Miller JL, Perfect JR. Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates. J Clin Microbiol. 2003;41(11):5233–5.PubMedCrossRef
16.
Diekema DJ, Petroelje B, Messer SA, Hollis RJ, Pfaller MA. Activities of available and investigational antifungal agents against Rhodotorula species. J Clin Microbiol. 2005;43(1):476–8.PubMedCrossRef
17.
Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review. J Antimicrob Chemother. 2005;55(3):312–5.PubMedCrossRef
18.
De Almeida GM, Costa SF, Melhem M, Motta AL, Szeszs MV, Miyashita F, et al. Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. Med Mycol. 2008;46(6):547–56.PubMedCrossRef
19.
Tuon FF, Costa SF. Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol. 2008;25(3):135–40.PubMedCrossRef
Metadata
Title
Fungemia due to Rhodotorula mucilaginosa in an immunocompetent, critically ill patient
Authors
Jesús Monterrubio Villar
Carmen González Velasco
Juan Diego Jiménez Delgado
Publication date
01-08-2012
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 4/2012
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-011-0347-6

Other articles of this Issue 4/2012

Journal of Infection and Chemotherapy 4/2012 Go to the issue

Note

Safety and efficacy of linezolid in 16 infants and children in Japan

Original Article

Evaluation of Seeplex® STD6 ACE Detection kit for the diagnosis of six bacterial sexually transmitted infections

Original Article

An evaluation of SNP-based PCR methods for the detection of β-lactamase-negative ampicillin-resistant Haemophilus influenzae

Original Article

Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species

Original Article

A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza

Original Article

Antibodies against mumps virus component proteins
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits